Metastatic PCa Is On the Rise
Between 2007 to 2013, the incidence of metastatic PCa increased by 7.1% annually.
Metastatic prostate cancer (PCa) has been increasing in incidence since 2007, particularly among men in an age group believed most likely to benefit from definitive treatment, according to a new report.
Using the National Cancer Data Base (2004–2013), researchers led by Edward M. Schaeffer, MD, of the Northwestern University Feinberg School of Medicine in Chicago, identified 767,550 men diagnosed with PCa at 1089 different healthcare facilities in the United States. Of these, 3% had metastatic disease at diagnosis.